Mounjaro and bum loss: what actually happens to fat distribution

Step 1: how tirzepatide creates fat loss in the first place

Tirzepatide is a dual GIP and GLP-1 receptor agonist — the only medicine of its kind licensed in the UK for weight management. By activating both receptors simultaneously, it slows the rate at which food leaves the stomach, reduces appetite-signalling in the brain, and makes it considerably easier to eat less without feeling deprived. The result is a sustained calorie deficit. When the body runs that deficit over weeks and months, it draws down stored fat for energy, and that process happens systemically, not at a single address. You can read a thorough overview of how tirzepatide works on the tirzepatide explainer page.

In the SURMOUNT-1 trial, published in the New England Journal of Medicine, participants lost an average of around 20–21% of their body weight over 72 weeks at the highest dose. That is a substantial reduction. Trials measured total bodyweight and waist circumference, so there is no published data saying "X% came from the gluteal region", but the magnitude of change is large enough that most parts of the body with meaningful fat deposits are affected.

One thing worth knowing early: the 2.5 mg starting pen exists to let your system adjust, not to produce rapid results. The clinical effect builds with each dose step, and most people find the pattern of fat loss becomes clearer after the first couple of months.

Step 2: why the bum and hips often change noticeably

The gluteal region, hips and thighs hold a large proportion of subcutaneous fat for many adults, particularly women. When total body fat falls significantly, areas with a high fat density are likely to show visible change simply because there was more to lose there. This is not a side effect; it is straightforward biology.

Some people find this change welcome. Others were not expecting it, particularly if they started treatment primarily to reduce abdominal fat. Both responses are entirely normal. There is no injection technique, timing adjustment or dietary trick that redirects fat loss away from one area and towards another, regional fat-reduction is a myth that neither Mounjaro nor any licensed medicine can deliver. The Mounjaro and fat loss page covers the wider picture of how total-body fat change tends to unfold over a treatment course.

If you are concerned about losing gluteal volume more than you wanted to, resistance training (particularly movements that load the glutes and legs) can help preserve lean muscle in that area as weight falls. Adequate dietary protein matters here too. A prescriber or registered dietitian can give you a personalised steer; general lifestyle advice from the NHS Better Health weight guidance is also a useful starting point.

Step 3: separating genuine side effects from expected body changes

The question of bum loss sometimes arrives alongside a different worry: rectal bleeding or discomfort noticed during treatment. Those are separate things and worth treating separately. Constipation is one of the more common gastrointestinal side effects of tirzepatide, as the NHS tirzepatide medicines page explains, and straining caused by constipation can occasionally lead to minor bleeding. That is not the same as fat loss from the gluteal area. If you notice rectal bleeding during treatment, read more on the Mounjaro and rectal bleeding page, and speak to a clinician promptly, do not assume it is treatment-related without getting it checked.

Changes in facial appearance are another thing people sometimes notice and attribute to a single cause. Weight loss at meaningful scale (15–20% of starting body weight is a significant physiological shift) affects face, neck, arms, legs and the gluteal area. Understanding the full scope of how body composition changes can help set realistic expectations; the dedicated Mounjaro bum page goes into more detail on what people commonly experience in that specific area.

There is also a practical note on timing worth raising: people who order treatment around a holiday or payday often ask whether a brief gap in injections changes their fat-distribution pattern. It does not. The body does not selectively reclaim fat from one area during a short break. Consistency matters for the overall rate of progress, but a week's interruption does not reset regional fat-loss patterns.

Step 4: putting it together and deciding what to do next

Mounjaro produces real, clinically significant weight loss, the Mounjaro weight loss results page walks through the trial evidence in detail. That loss is distributed across the body, and the gluteal region changes because it is a major fat depot, not because tirzepatide has any particular affinity for it. You cannot direct where fat is lost, but you can support the quality of the tissue that remains through nutrition and resistance exercise.

If you are wondering whether tirzepatide is suitable for you (whether for weight management generally or because you want to understand what body-composition changes to expect) the most useful step is a conversation with a prescriber. On the Mounjaro cost page you will find a clear breakdown of what private treatment involves financially. When you are ready to discuss your own situation, speak to our prescribers through a free consultation; a GPhC-registered independent prescriber reads your answers personally, the same day.